Skip to main contentAI and Advanced
/
SAKAR · NSEMarket ticker unavailable · configure an authorised index feed
SA
NSE · Equity shares · Biotechnology & Drugs-46.00 · -4.05%
Sakar Healthcare SAKAR
NSE:INR 1,090
BSE:Not available
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for SAKAR
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 1,136
Day rangeINR 1,042.7 — INR 1,143.9
52-week rangeINR 321.05 — INR 1,211
Volume1.64 L
Market cap1,851.69
P/E36.41
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)251.74
Net Income (INR Cr)30.48
Rev Growth (5 Year %)21.59
EPS Growth (5 Year %)14.1
P/E Ratio36.41
Book Value144.43
EPS13.7
Price/BV7.55Computed
Research path: Interpret Sakar Healthcare's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
SAKARSakar Healthcare1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 481.01 | 415.26 | 388.66 |
| Cash Equivalents | 0.04 | Not available | 0 |
| Other Liabilities Total | 2.81 | 2.66 | 2.29 |
| Long Term Debt | 31.35 | 53.59 | 54.96 |
| Common Stock Total | 22.25 | 21.95 | 21.75 |
| Other Current Assets Total | 20.07 | 14.1 | 0 |
| Total Assets | 481.01 | 415.26 | 388.66 |
| Current Portof LT Debt/Capital Leases | 15.23 | 11.42 | 10.52 |
| Cash | 0.22 | 0.31 | 0.47 |
| Total Equity | 324.45 | 285.48 | 262.33 |
| Retained Earnings(Accumulated Deficit) | 302.2 | 263.53 | 85.34 |
| Total Common Shares Outstanding | 2.19 | 2.19 | 1.9 |
| Tangible Book Valueper Share Common Eq | 144.43 | 127.96 | 137.01 |
| Total Liabilities | 156.56 | 129.79 | 126.33 |
| Total Debt | 70.53 | 86.37 | 79.35 |
| Cashand Short Term Investments | 0.26 | 0.31 | 0.47 |
| Total Receivables Net | 50.08 | 30.72 | 42.24 |
| Notes Payable/Short Term Debt | 23.95 | 21.36 | 13.88 |
| Deferred Income Tax | 12.86 | 10.34 | 10.02 |
| Accounts Receivable-Trade Net | 50.08 | 30.72 | 20.91 |
| Property/Plant/Equipment Total-Net | 323.02 | 321.05 | 313.15 |
| Total Current Liabilities | 109.54 | 63.19 | 59.06 |
| Total Inventory | 70.04 | 43.59 | 28.06 |
| Accounts Payable | 51.54 | 21.07 | 27.45 |
| Other Currentliabilities Total | 18.82 | 9.34 | 7.21 |
| Total Long Term Debt | 31.35 | 53.59 | 54.96 |
| Intangibles Net | 7.43 | 4.61 | 1.46 |
| Other Long Term Assets Total | 9.8 | 0.57 | 2.14 |
| Note Receivable-Long Term | 0.3 | 0.3 | 0.3 |
| Total Current Assets | 140.46 | 88.73 | 71.61 |
| Short Term Investments | Not available | 0 | Not available |
| Accumulated Depreciation Total | Not available | Not available | -56.3 |
| Other Equity Total | Not available | Not available | -0.71 |
| Prepaid Expenses | Not available | Not available | 0.84 |
| Additional Paid-In Capital | Not available | Not available | 155.95 |
| Property/Plant/Equipment Total-Gross | Not available | Not available | 369.12 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio2.41
Price to Sale Ratio7.36
Growth
Debt 5Yr CAGR %10.61
Margins
Operating Margin 12m18
Operating Margin 5y Avg15.67
Net Profit Margin 12m12.11
Net Profit Margin 5y10.38
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,936.55 | 4.65 L | 38.87 | — |
| Divi's Laboratories | INR 7,363.8 | 1.95 L | 74.03 | — |
| Torrent Pharmaceuticals | INR 4,981 | 1.69 L | 76.43 | — |
| Cipla | INR 1,408.25 | 1.14 L | 28.01 | — |
| Zydus Lifesciences | INR 1,121.5 | 1.12 L | 21.29 | — |
Shareholding
Ownership
- Promoter
- 52.52%
- FII
- 12.13%
- Other
- 35.35%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Multibagger healthcare stock retraces from near record high. Do you own?Market news · 21 May 2026, 3:24 pm
Sakar Healthcare stock had touched a record high of ₹ 829.60 in the last trading session, while its 52-week low stands at ₹ 306, hit on 23 May last year. NSE data shows that 1.55 lakh shares of the healthcare firm were traded today.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 12 December 2025Market news · 12 Dec 2025, 6:28 am
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today - Yatra Online, Natco Pharma, Sakar Healthcare, Ramco Systems, Prataap Snacks
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 7 November 2025Market news · 7 Nov 2025, 6:17 am
Breakout stocks to buy or sell: Sumeet Bagadia recommends five breakout stocks to buy today: Aditya Infotech, Senores Pharma, Atlanta Electricals, Anand Rathi, Sakar Healthcare
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 19 June 2025Market news · 19 Jun 2025, 6:43 am
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — Sakar Healthcare, Yuken India, DEE Development Engineers, NDR Auto Components, and Pearl Global Industries.
Corporate actions
Events
- board MeetingsTo consider and approve the financial results for the period ended Jun 30, 2026
- board MeetingsTo consider other business matters.
- board MeetingsTo consider other business matters.
- board MeetingsTo consider other business matters.
- board MeetingsTo consider other business matters.
- board MeetingsAudited results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Sakar Healthcare
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Sakar Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules and vials & lyophilized injections. The Company's oncology products include oral solid dosage (tablet & capsule), liquid injection, lyophilized injection, active pharmaceutical ingredient (API), CDMO products and CRAMs. It has a presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and in Europe. It operates in over 50 countries globally and has approximately 292 registered products. It exports to Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering around 38 countries with more than 250 brands registered.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- SAKAR
Questions
Stock FAQ
What is the symbol and ISIN of Sakar Healthcare?
Sakar Healthcare has the symbol SAKAR and ISIN - INE732S01012.
What is the current price of Sakar Healthcare?
Sakar Healthcare is currently trading at INR 1,090.00.
What are the year high and year low of Sakar Healthcare?
Sakar Healthcare has a year high of INR 1,211.00 and a year low of INR 321.05.
What is the market capitalization of Sakar Healthcare?
Sakar Healthcare has a market capitalization of INR 1,851.69 crore.
What is the P/E ratio of Sakar Healthcare?
Sakar Healthcare has a P/E ratio of 36.41.
What is the dividend yield of Sakar Healthcare?
Sakar Healthcare has a dividend yield of 0.00%.
How is the financial performance of Sakar Healthcare based on revenue, net income, and EPS?
Sakar Healthcare has revenue of INR 251.74 crore, net income of INR 30.48 crore, and EPS of INR 13.69.
What is the book value of Sakar Healthcare?
Sakar Healthcare has a book value of INR 144.43.
What is the debt-to-equity ratio of Sakar Healthcare?
Sakar Healthcare has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Sakar Healthcare?
Sakar Healthcare has a price-to-book ratio of 7.55 and a price-to-sales ratio of 7.36.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.